NO146909C - Fremgangsmaate til fremstilling av terapeutisk virksomme pyrrolidinderivater. - Google Patents

Fremgangsmaate til fremstilling av terapeutisk virksomme pyrrolidinderivater.

Info

Publication number
NO146909C
NO146909C NO762791A NO762791A NO146909C NO 146909 C NO146909 C NO 146909C NO 762791 A NO762791 A NO 762791A NO 762791 A NO762791 A NO 762791A NO 146909 C NO146909 C NO 146909C
Authority
NO
Norway
Prior art keywords
pyrrolide
ingredients
procedure
preparation
therapeutically effective
Prior art date
Application number
NO762791A
Other languages
English (en)
Norwegian (no)
Other versions
NO146909B (no
NO762791L (hu
Inventor
Giorgio Pifferi
Mario Pinza
Original Assignee
Isf Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isf Spa filed Critical Isf Spa
Publication of NO762791L publication Critical patent/NO762791L/no
Publication of NO146909B publication Critical patent/NO146909B/no
Publication of NO146909C publication Critical patent/NO146909C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO762791A 1975-08-13 1976-08-11 Fremgangsmaate til fremstilling av terapeutisk virksomme pyrrolidinderivater. NO146909C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT26326/75A IT1045043B (it) 1975-08-13 1975-08-13 Derivati pirrolidinici

Publications (3)

Publication Number Publication Date
NO762791L NO762791L (hu) 1977-02-15
NO146909B NO146909B (no) 1982-09-20
NO146909C true NO146909C (no) 1982-12-29

Family

ID=11219233

Family Applications (1)

Application Number Title Priority Date Filing Date
NO762791A NO146909C (no) 1975-08-13 1976-08-11 Fremgangsmaate til fremstilling av terapeutisk virksomme pyrrolidinderivater.

Country Status (27)

Country Link
US (1) US4118396A (hu)
JP (1) JPS5822034B2 (hu)
AR (1) AR212176A1 (hu)
AT (1) AT353783B (hu)
AU (1) AU506651B2 (hu)
BE (1) BE845099A (hu)
CA (1) CA1077947A (hu)
CH (1) CH624935A5 (hu)
CS (1) CS214766B2 (hu)
DD (1) DD127966B3 (hu)
DE (1) DE2635853C2 (hu)
DK (1) DK156055C (hu)
ES (1) ES450643A1 (hu)
FI (1) FI62290C (hu)
FR (1) FR2320741A1 (hu)
GB (1) GB1550160A (hu)
HU (1) HU173742B (hu)
IN (1) IN144871B (hu)
IT (1) IT1045043B (hu)
MX (1) MX4717E (hu)
NL (1) NL179052C (hu)
NO (1) NO146909C (hu)
NZ (1) NZ181726A (hu)
PL (1) PL101471B1 (hu)
SE (1) SE420599B (hu)
SU (1) SU663302A3 (hu)
YU (1) YU40147B (hu)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1075564B (it) * 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
IT1075280B (it) 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
GB1580559A (en) * 1977-11-24 1980-12-03 Wyeth John & Brother Ltd Amide cerivatives
IT1141287B (it) * 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
NL8004025A (nl) * 1979-08-09 1981-02-11 Hoffmann La Roche Pyrrolidinederivaten en werkwijze voor het bereiden daarvan alsmede geneesmiddel.
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
IT1206699B (it) * 1984-02-27 1989-04-27 Isf Spa Procedimento per preparare derivati di pirrolidone.
CH666483A5 (de) * 1985-01-16 1988-07-29 Lonza Ag Verfahren zur herstellung von thiotetronsaeure.
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
EP0223328B1 (en) 1985-07-26 1992-01-29 Denki Kagaku Kogyo Kabushiki Kaisha Process for producing oxiracetam
HU195773B (en) * 1985-09-24 1988-07-28 Lonza Ag Process for preparing alkyl esters of 4-alkoxy-3-pyrrolin-2-on-1-yl-acetic acid
IL80071A0 (en) * 1985-09-24 1986-12-31 Lonza Ag Pyrrolidine acetamide derivatives
CH668423A5 (de) * 1986-06-19 1988-12-30 Lonza Ag Verfahren zur herstellung von 4-alkoxy-3-pyrrolin-2-onen.
US4677114A (en) * 1985-11-22 1987-06-30 Warner-Lambert Company Pyrrolidone-2 derivatives and pharmaceutical compositions thereof
CH668424A5 (de) * 1986-06-26 1988-12-30 Lonza Ag 4-benzyloxy-3-pyrrolin-2-on-l-yl-acetamid, dessen herstellung und verwendung.
CH668422A5 (de) * 1986-06-26 1988-12-30 Lonza Ag 4-benzyloxy-3-pyrrolin-2-on, dessen herstellung und verwendung zur synthese von tetramsaeure.
IT1224168B (it) * 1986-08-01 1990-09-26 Finanziaria R F Spa Ora Finanz Derivati del pirrolidin-2-one ad attivita' nootropa
CH667655A5 (de) * 1986-09-24 1988-10-31 Lonza Ag Verfahren zur herstellung von 4-alkoxy-2(5h)-thiophenonen.
CH670644A5 (hu) * 1986-12-18 1989-06-30 Lonza Ag
US5202345A (en) * 1987-08-19 1993-04-13 Shionogi & Co., Ltd. Carbamoylpyrrolidone derivatives and drugs for senile dementia
CA1305148C (en) * 1987-08-19 1992-07-14 Hiromu Matsumura Carbamoylpyrrolidone derivatives and drugs for senile dementia
DE3813416A1 (de) * 1988-04-21 1989-11-02 Hoechst Ag 3,4-dihydroxypyrrolidin-2-on-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
JP2660201B2 (ja) * 1988-08-05 1997-10-08 塩野義製薬株式会社 新規ピロロ［１，４］ベンゾジアゼピン誘導体および老人性痴呆薬
DE58909320D1 (de) * 1988-09-06 1995-08-03 Lonza Ag Verfahren zur Herstellung von 5-Alkyltetramsäuren.
IL93051A0 (en) * 1989-01-17 1990-11-05 Hoffmann La Roche ((5-oxo-2-pyrrolidinyl)methyl)cyclohexaneacetamides,their preparation and pharmaceutical compositions containing them
FI95034C (fi) * 1989-03-15 1995-12-11 Lonza Ag Menetelmä 1,3-substituoidun tetrahydro-1H-tieno/3,4-d/-imidatsol-2(3H)-on-4-ylideenipentaanihappoesterin valmistamiseksi
CH680293A5 (hu) * 1990-06-26 1992-07-31 Lonza Ag
JP3038032B2 (ja) * 1991-03-25 2000-05-08 日清製粉株式会社 血小板凝集抑制薬
US7608636B2 (en) 2000-12-28 2009-10-27 Hamilton Pharmaceuticals, Inc. Medicines for treatment and prevention of neurogenic pain
WO2007065634A1 (en) * 2005-12-07 2007-06-14 Ucb Pharma, S.A. 3-carboxy- 2-oxo-1 -pyrrolidine derivatives and their uses
CN102227217A (zh) 2008-10-16 2011-10-26 约翰斯.霍普金斯大学 改善认知功能的方法和组合物
EP2533645B1 (en) * 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
DK2968220T3 (da) 2013-03-15 2021-06-14 Agenebio Inc Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
BR112017025031B1 (pt) 2015-05-22 2023-03-21 Agenebio, Inc Composições farmacêuticas de liberação prolongada de levetiracetam
CN105820102A (zh) * 2016-05-10 2016-08-03 武汉工程大学 奥拉西坦的合成工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011886B (de) * 1952-04-29 1957-07-11 Waldemar Kutscher Dr Ing Dr Me Verfahren zur Herstellung von Aminoalkylpyrrolen
GB1309692A (en) * 1970-02-13 1973-03-14 Ucb Sa N-substituted lactams
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
US3541111A (en) * 1968-05-08 1970-11-17 Du Pont Pyrrolinecarboxanilide compounds
US3577432A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-phenoxypyrrolidines

Also Published As

Publication number Publication date
BE845099A (fr) 1977-02-11
FI762314A (hu) 1977-02-14
DK156055B (da) 1989-06-19
FR2320741A1 (fr) 1977-03-11
AT353783B (de) 1979-12-10
AU1679776A (en) 1978-02-16
DD127966A5 (de) 1977-10-26
CS214766B2 (en) 1982-05-28
DK365176A (da) 1977-02-14
DD127966B3 (de) 1983-03-30
CA1077947A (en) 1980-05-20
NZ181726A (en) 1978-09-20
ATA589476A (de) 1979-05-15
DE2635853C2 (de) 1984-05-30
US4118396A (en) 1978-10-03
SE7608938L (sv) 1977-02-14
YU196476A (en) 1982-06-30
FR2320741B1 (hu) 1979-03-02
JPS5223072A (en) 1977-02-21
ES450643A1 (es) 1977-08-01
AR212176A1 (es) 1978-05-31
PL101471B1 (pl) 1978-12-30
HU173742B (hu) 1979-08-28
YU40147B (en) 1985-08-31
NL179052B (nl) 1986-02-03
FI62290C (fi) 1982-12-10
NO146909B (no) 1982-09-20
GB1550160A (en) 1979-08-08
JPS5822034B2 (ja) 1983-05-06
AU506651B2 (en) 1980-01-17
NL179052C (nl) 1986-07-01
DE2635853A1 (de) 1977-02-24
IT1045043B (it) 1980-04-21
SE420599B (sv) 1981-10-19
MX4717E (es) 1982-08-13
CH624935A5 (hu) 1981-08-31
IN144871B (hu) 1978-07-22
DK156055C (da) 1989-12-04
FI62290B (fi) 1982-08-31
NL7608946A (nl) 1977-02-15
NO762791L (hu) 1977-02-15
SU663302A3 (ru) 1979-05-15

Similar Documents

Publication Publication Date Title
NO146909C (no) Fremgangsmaate til fremstilling av terapeutisk virksomme pyrrolidinderivater.
NO142034C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoletere.
NO155290C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme sulfonylurinstoffderivater.
NO143219C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO147751C (no) Fremgangsmaate til fremstilling av 4-hydroksypyrrolidin-2-on-amider.
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
NO143796C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme piperazinyliminorifamyciner
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE433610B (sv) Forfarande for framstellning av aromatiska uretaner
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
NO781878L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner.
SE419983B (sv) Forfarande for framstellning av finkornig, fast cyanurklorid
NO146141C (no) Fremgangsmaate til fremstilling av aminocyklitolantibiotika
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
SE7600910L (sv) Forfarande for framstellning av polyuretaner
NO153221C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 6-metoksy-alfa-karboksypenicilliner.
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE7600847L (sv) Nytt forfarande for framstellning av 8-bromtienotriazolo-1,4-diazepiner
NO150157C (no) Fremgangsmaate til fremstilling av 6,11-dihydro-11-okso-dibenz(b,e)-oksepin-2-eddiksyre
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE7608453L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
DK153776A (da) Fremgangsmade til treimpregnering